John D Quisel Insider Trading
Get free email notifications about insider trading for John D Quisel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John D Quisel. John D Quisel is a EVP, CBO and Secretary in ACCELERON PHARMA INC ($XLRN) and a EVP, Chief Business Officer in ACCELERON PHARMA INC ($XLRN) and a SVP Gen. Counsel & Secretary in ACCELERON PHARMA INC ($XLRN) and a SVP, Bus. Dev., GC & Secretary in ACCELERON PHARMA INC ($XLRN) and a SVP, Corp. Dev., GC & Sec. in ACCELERON PHARMA INC ($XLRN) and a VP General Counsel & Secretary in ACCELERON PHARMA INC ($XLRN).
Address: 128 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which John D Quisel is an Insider
ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John D Quisel: EVP, Chief Business Officer, EVP, CBO and Secretary, SVP, Corp. Dev., GC & Sec., SVP, Bus. Dev., GC & Secretary, SVP Gen. Counsel & Secretary, VP General Counsel & Secretary
Holdings: 57,558 shares
Current Value: $1,366,427
Latest Transaction: Jan 03 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John D Quisel
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 52.52 | 4,242 | 222,790 | 53,316 | 57.6 K to 53.3 K (-7.37 %) |
Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 52.51 | 1,600 | 84,016 | 57,558 | 59.2 K to 57.6 K (-2.70 %) |
Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 52.52 | 4,242 | 222,790 | 53,316 | 57.6 K to 53.3 K (-7.37 %) |
Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 52.51 | 1,600 | 84,016 | 57,558 | 59.2 K to 57.6 K (-2.70 %) |
Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 45.23 | 3,584 | 162,104 | 59,158 | 62.7 K to 59.2 K (-5.71 %) |
Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Sell | S | 45.23 | 3,584 | 162,104 | 59,158 | 62.7 K to 59.2 K (-5.71 %) |
Jul 11 2019 | XLRN | ACCELERON PHARMA I ... | Quisel John D | EVP, Chief Business ... | Option Exercise | M | 7.12 | 1,562 | 11,121 | 0 |